Drug Profile
F 180
Latest Information Update: 21 Nov 2006
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Developer University of Valencia
- Class Vasopressors
- Mechanism of Action Vasopressin 1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Portal hypertension
Most Recent Events
- 04 Sep 2001 Preclinical development for Portal hypertension in Spain (Unknown route)